Status:
ENROLLING_BY_INVITATION
Prescription Opioid Discontinuation: Honoring Patient Insights and Experience to Support Safe and Caring Transitions -- Decision Aid Pilot
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
University of Arkansas
University of Washington
Conditions:
Opioid Tapering
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Because of recent policies to decrease opioid use, some people using long-term opioid therapy (LTOT) are encouraged or required to stop (discontinue) taking opioids. That has led experts to be concern...
Eligibility Criteria
Inclusion
- EHR-based inclusion criteria:
- age 18 or older
- LTOT in the past 18 months (LTOT is ≥60 days of ≥50 MEDs day in each of 2 consecutive 90-day periods with medication treatment for OUD excluded)
- Inclusion criteria confirmed by participant
- Have been taking opioids for chronic pain for at least 6 months
- Able to speak and read English
- EHR-based exclusion criteria:
- cancer diagnosis in the last 5 years (excluding non-melanoma skin cancers)
- current palliative or hospice care
- cognitive disability
- psychiatric hospitalization in the last year
- surgery in the last 6 months
- current residence in an inpatient rehabilitation or skilled nursing facility
- Exclusion criteria determined by study
- \- participated in an interview for Aim 1 of this study
Exclusion
Key Trial Info
Start Date :
October 29 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07202026
Start Date
October 29 2025
End Date
September 1 2026
Last Update
November 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Washington Health Research Institute
Seattle, Washington, United States, 98101